Natural Ingredients in Atopic Dermatitis and Other Inflammatory Skin Disease

REFERENCES

1. Fowler JF Jr, Woolery-Lloyd H, Waldorf H, Saini R. Innovations in natural ingredients and their use in skin care. J Drugs Dermatol. 2010;9(suppl 6):s72-s83.
2. Brown DJ, Dattner AM. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol. 1998;134(11):1401-1404.
3. Baumann L. Oatmeal. Skin & Allergy News. 2004;35:44-45.
4. Kurtz ES, Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J Drugs Dermatol. 2007;6(2):167-170.
5. Eichenfield LF, Fowler JF Jr, Rigel DS, Taylor SC. Natural advances in eczema care. Cutis. 2007;80(suppl 6):s2-s16.
6. Sur R, Nigam A, Grote D, Liebel F, Southall MD. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch Dermatol Res. 2008;300(10):569-574.
7. Matheson JD,Clayton J, Muller MJ. The reduction of itch during burn wound healing. J Burn Care Rehabil. 2001;22(1):76-81.
8. Alexandrescu DT, Vaillant JG, Dasanu CA. Effect of treatment with a colloidal oatmeal lotion on the acneiform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors. Clin Exp Dermatol. 2007;32(1):71-74.
9. Talsania N, Loffeld A, Orpin SD. Colloidal oatmeal lotion is an effective treatment for pruritus caused by erlotinib. Clin Exp Dermatol. 2008;33(1):108.
10. Lee PW, Krakowski A, Chayavichitsilp P, Nebus J, Wallo W, Eichenfield LF. Evaluating the tolerance of a colloidal oatmeal cream and cleanser in infants and children with atopic dermatitis. Poster presented at: 34th Annual Meeting of the Society of Pediatric Dermatology, July 2008.
11. Food and Drug Administration, HHS. Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph. Federal Register 68 (4 June 2003):33362-33381.
12. Nebus J, Wallo W, Nystrand G, Fowler J. A daily oat based skin care regimen for atopic skin. Poster presented at: 67th Annual Meeting of the American Academy of Dermatology, March 6-10, 2009; San Francisco, CA.
13. Martin K, Southall M, Lyte P, et al. Parthenolide-free extract of feverfew: an extract with effective anti-irritant activity in vitro. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, LA.
14. Sur R, Martin K, Liebel F, Lyte P, Shapiro S, Southall M. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium). Inflammopharmacology. 2009;17(1):42-49.
15. Miller D, Wallo W, Leyden JL. Facial Tolerance and Efficacy of a Daily Moisturizer Containing a Purified Feverfew Extract and SPF 30 in a Sensitive Skin Population. Poster presented at: 67th Annual Meeting of the American Academy of Dermatology; March 6-10, 2009; San Francisco, CA.
16. Halas L, Liebel F, Martin K. Clinical evaluation of a formulation containing parthenolide-free extract of feverfew for shaving-induced irritation. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, LA.
17. Linton GM, Anthonavage M, Southall M. Broad antioxidant activity of feverfew provides all day skin protection from oxidative stress. Poster presented at: 66th Annual Meeting of the American Academy of Dermatology; February 1-5, 2008; San Antonio, TX.
18. Martin K, Sur R, Liebel F. Parthenolide-depleted Feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression. Arch Dermatol Res. 2008;300(2):69-80.
19. Bedi MK, Shenefelt PD. Herbal therapy in dermatology. Arch Dermatol. 2002;138(2):232-242.
20. Patzelt-Wenczler R, Ponce-Pöschl E. Proof of efficacy of Kamillosan® cream in atopic eczema. Eur J Med Res. 2000;5(4):171-175.
21. Maiche AG, Gröhn P, Mäki-Hokkonen H. Effects of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol. 1991;3(3):395-396.
22. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol. 2010;24(2):168-172.
23. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11(6):355-361.
24. Kolbe L, Immeyer J, Batzer J, et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Dermatol Res. 2006;298(1):23-30.
25. Weber TM, Ceilley RI, Buerger A, et al. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A. J Cosmet Dermatol. 2006;5(3):227-232.
26. Amer M, Metwalli M. Topical liquiritin treatment improves melasma. Int J Dermatol. 2000;39(4):299-301.
27. Kobayashi D, Kusama M, Onda M, Nakahata N. The effect of pantothenic acid deficiency on keratinocyte proliferation and the synthesis of keratinocyte growth factor and collagen in fibroblasts. J Pharmacol Sci. 2011;115(2):230-234.
28. Cerio R, Dohil M, Jeanine D, Magina S, Mahé E, Stratigos AJ. Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice. J Drugs Dermatol. 2010;9(9):1116-1120.
29. Zhou M, Robards K, Glennie-Holmes M, Helliwell S. Oat lipids. J Am Oil Chem Soc. 1999;76:159-169.
30. Vollhardt J, Fielder DA, Redmont MJ. Identification and cosmetic application of powerful anti-irritant constituents of oat grain. Poster presented at: XXI IFSCC International Congress; 2000; Berlin, Germany. Proceedings; 395-402.
31. Southall M, Pappas A, Nystrand G, Nebus J. Oat oil improves the skin barrier. Dermatologist. 2012(suppl):1-4. http://www.the-dermatologist.com/sites/default/files/Aveeno_SeptInsert_2012_0.pdf. Accessed July 17 2013.
32. Grais ML. Role of colloidal oatmeal in dermatologic treatment of the aged. AMA Arch Derm Syphilol. 1953;68(4):402-407.
33. Data on file, Johnson & Johnson 2012.

AUTHOR CORRESPONDENCE